The emergence of two highly effective GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — has given physicians and patients more options than ever for physician-supervised weight loss. But with two strong candidates, patients increasingly ask: which one is better? The honest answer is that the choice depends on your individual health profile, insurance situation, and treatment goals — but the clinical evidence does give us meaningful guidance.
Comparing Weight Loss Results
Head-to-head clinical data and cross-trial comparisons consistently show tirzepatide producing greater absolute weight loss than semaglutide at comparable timepoints. In the SURMOUNT-1 trial, tirzepatide 15 mg produced an average weight loss of 20.9% over 72 weeks. In the STEP 1 trial, semaglutide 2.4 mg produced 14.9% weight loss at 68 weeks. The dual GIP/GLP-1 mechanism of tirzepatide appears to confer a meaningful additional weight loss benefit. However, this difference narrows at lower doses of tirzepatide, and individual responses vary significantly.
Semaglutide vs. Tirzepatide: Key Comparisons
- Mechanism: Semaglutide = GLP-1 receptor agonist only; tirzepatide = dual GIP+GLP-1 agonist
- Average weight loss: Semaglutide ~15%; tirzepatide ~20%+ at maximum dose
- Side effects: Similar GI profile — nausea, constipation, vomiting. Some data suggests tirzepatide has comparable or slightly better tolerability
- Diabetes benefit: Both reduce HbA1c; tirzepatide may be superior for glucose control
- Cost and availability: Varies significantly by insurance coverage and shortage status
- Dosing: Both are weekly subcutaneous injections with similar titration protocols
Making the Decision with Your Physician
The best choice between semaglutide and tirzepatide requires an individualized evaluation. Dr. Arpana Pillay at Vish Medical assesses each patient's medical history, comorbidities, insurance coverage, and weight loss goals before recommending a specific GLP-1 medication. A $99 consultation is the starting point. Book your appointment to take the first step toward physician-supervised weight loss with semaglutide or tirzepatide.